APPENDIX 2.
PEER REVIEW RELATIONSHIPS WITH INDUSTRY AND OTHER ENTITIES—2013 ACCF/AHA KEY DATA ELEMENTS AND DEFINITIONS FOR MEASURING THE CLINICAL MANAGEMENT AND OUTCOMES OF PATIENTS WITH ACUTE CORONARY SYNDROMES AND CORONARY ARTERY DISEASE
| Peer Reviewer | Representation | Consultant | Speaker | Ownership/ Partnership/ Principal |
Research | Institutional, Organizational, or Other Financial Benefit |
Expert Witness |
|---|---|---|---|---|---|---|---|
| Robert A. Guyton | ACCF—Board of Trustees | None | None | None | • National Institutes of Health | None | • 2011—Represented defendant—aortic dissection during coronary bypass |
| Jafna L. Cox | ACCF—Board of Governors |
|
None | None | None | • Heart and Stroke Foundation of Nova Scotia | None |
| Lloyd Klein | American Heart Association | None | None | None | None | None | None |
| Biykem Bozkurt | ACCF/AHA Data Standards Task Force Lead Reviewer | None | None | None |
|
|
None |
| Darice Allard | Official Reviewer—Society of Chest Pain Centers and Providers | None | None | None | None | None | None |
| Les R. Becker | Official Reviewer—National Association of Emergency Medical Technicians | None | None | None | None | None | None |
| Deborah Diercks | Official Reviewer—American College of Emergency Physicians | None | None | None | None | None | None |
| Robert S. Gibson | Official Reviewer—American College of Physicians | None | None | None | None | None | None |
| Diane Gurney | Official Reviewer—Emergency Nurses Association | None | None | None | None | None | None |
| Jane Nelson-Worel | Official Reviewer–Preventive Cardiovascular Nurses Association | None | None | None | None | None | None |
| Richard L. Prager | Official Reviewer—Society of Thoracic Surgeons | None | None | None | None | None | None |
| Clyde B. Schecter | Official Reviewer–American College of Preventive Medicine | None | None | None | None | None | None |
| David K. Tan | Official Reviewer—National Association of EMS Physicians | None | None | None | None | None | None |
| Shari Targum | Official Reviewer—Food and Drug Association | None | None | None | None | None | None |
| Michael D. Brown | Content Reviewer | None | None | None | None | None | None |
| Angus Jameson | Content Reviewer | None | None | None | None | None | None |
| Robert L. McNamara | Content Reviewer |
|
None | None | None | None | None |
| Mark Menegus | Content Reviewer | None | None | None | None | None | None |
| Joyce L. Ross | Content Reviewer | None | None | None | None | None | None |
| Thomas Tsai | Content Reviewer | None | None | None | None | None | None |
This table represents the relevant relationships with industry and other entities that were disclosed by reviewers at the time of peer review. It does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% of the voting stock or share of the business entity, or ownership of $10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. A relationship is considered to be modest if it is less than significant under the preceding definition. Relationships in this table are modest unless otherwise noted. Names are listed in alphabetical order within each category of review. Participation in the peer review process does not imply endorsement of this document.